000 | 01498 a2200421 4500 | ||
---|---|---|---|
005 | 20250511125614.0 | ||
264 | 0 | _c19770630 | |
008 | 197706s 0 0 eng d | ||
022 | _a0090-3019 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSundt, T M | |
245 | 0 | 0 |
_aPhysiological considerations important for the management of vasospasm. _h[electronic resource] |
260 |
_bSurgical neurology _cMay 1977 |
||
300 |
_a259-67 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.; Review | ||
650 | 0 | 4 |
_aAlbuterol _xtherapeutic use |
650 | 0 | 4 |
_aAminophylline _xtherapeutic use |
650 | 0 | 4 |
_aAutonomic Nervous System _xphysiology |
650 | 0 | 4 | _aBlood Pressure |
650 | 0 | 4 | _aCerebrovascular Circulation |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIntracranial Aneurysm _xsurgery |
650 | 0 | 4 |
_aIschemic Attack, Transient _xetiology |
650 | 0 | 4 |
_aIsoproterenol _xtherapeutic use |
650 | 0 | 4 |
_aMagnesium Sulfate _xtherapeutic use |
650 | 0 | 4 | _aMuscle Contraction |
650 | 0 | 4 |
_aMuscle, Smooth _xphysiology |
650 | 0 | 4 |
_aNeurosurgery _xadverse effects |
650 | 0 | 4 |
_aNucleotides, Cyclic _xbiosynthesis |
650 | 0 | 4 |
_aReceptors, Adrenergic _xmetabolism |
650 | 0 | 4 |
_aReserpine _xtherapeutic use |
650 | 0 | 4 |
_aSubarachnoid Hemorrhage _xcomplications |
650 | 0 | 4 |
_aSympathomimetics _xtherapeutic use |
650 | 0 | 4 | _aTime Factors |
700 | 1 | _aSzurszewski, J | |
700 | 1 | _aSharbrough, F W | |
773 | 0 |
_tSurgical neurology _gvol. 7 _gno. 5 _gp. 259-67 |
|
999 |
_c349041 _d349041 |